Founded in 2016, BICO (formerly CELLINK) is the leading bio convergence company in the world. By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better.
Brinter is a trailblazing Finnish bioprinting company. We provide comprehensive 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. We strive to learn our client’s specific applications and needs. Therefore, each Brinter® Bioprinter is custom-built.
The project Chiron is part of Eurostar, a european programme to foster R&D and international collaboration between companies and research institutes to create innovative products and technologies.
Chiron is an international collaboration between two SMEs (Concr3de BV and IPC,Innovative Polymer Compounds) and two research centers (University Medical Center of Utrecht and the Trinity College of Dublin).
The aim of the project is to create a fast multimaterial bioprinting platform for the research and production in the biomedical sector to create a portfolio of biomaterials and applications of the technology.
Ourobionics is a start-up with a simple, but holistic, and innovative vision: to go beyond bioprinting. Ourobionics strives to empower researchers, developers, and manufacturers in various fields, by facilitating their journey from the lab to the market.
Our proprietary bioprinting technology, DomoBIO, is a multi-technology and multi-tool bioprinter with focus on regenerative medicine especially designed to become a multi-purpose technology and contribute to democratize the biofabrication by making accessible medical research.
Allegro 3D is an emerging 3D printing and bioprinting company located in San Diego, a world hub for biotechnology. At the convergence of advanced additive manufacturing, stem cell biology and biomaterials, Allegro 3D’s expertise in bioprinting and biomaterials enables high-throughput manufacturing of advanced biomedical devices, cell matrices and precision human tissues for cell culture, drug screening, therapeutics and regenerative medicine.
Axolotl Biosystems creates high-resolution desktop 3D bioprinters and bioinks capable of producing functional three dimensional living tissues. Built to reduce the high costs of traditional 3D bioprinting systems, the accessibility to researchers and flexible open system architecture for construct design is making Axolotl Biosystems products the platform of choice for leading bioengineering laboratories around the world.
Based in Gothenburg Sweden, Fluicell is a company that has commercialized a product portfolio to study single cells, primarily in the field of drug development. Fluicell’s existing products are the research tools Biopen® and Dynaflow® Resolve, which today allow researchers to investigate the effects of drugs on individual cells at a unique level of detail. As a further development of Fluicell's existing product portfolio, the company has developed a unique high-resolution bioprinting technology in both 2D and 3D under the name Biopixlar®. With this system, complex tissue-like structures can be created where positioning of individual cells can be controlled.
Advanced Solutions is dedicated to the discovery, design, and development of integrated software and hardware solutions for the fields of science that involve living organisms, molecular biology, and biotechnology.
Headquartered in New York, NY, VIVAX BIO is a global biotech company focusing on 3D bioprinting and working on the whole range of the hardware, materials, technologies, and products constituting this nascent industry. Our product pipeline – from the earliest stages of R&D to commercial manufacturing - comprises items as diverse as our FABION bioprinter, a new line of bioprinters based on different technologies, including in situ portable bioprinters, and various tissue and organ constructs.
Unleash the power of electro-hydrodynamically enhanced bioprinting. The FLUX-1 is an advanced bioprinter that combines conventional bioprinting technologies with the advanced capabilities of electro-hydrodynamic printing (EHDP).
FluidForm has the exclusive license to FRESH technology from Carnegie Mellon University, and is focused on advancing applications of the technology in biofabrication, regenerative medicine and other industries.
Inventia Life Science Pty Ltd (ILS) is an Australian privately-owned company established in Sydney in 2013. ILS has a core focus on the development, manufacture and sale of equipment and reagents for advanced medical research assays by means of 3D bioprinting.
Volumetric, Inc. was founded in 2018 by Jordan Miller and Bagrat Grigoryan. Our mission is to empower the next generation of advanced biofabrication with high quality materials and systems for 3D bioprinting.